The Cutaneous Lymphoma Foundation offers Young Investigator Travel Awards to medical meetings each year to new physicians and scientists in the field of cutaneous lymphoma research.
Since 2003, this annual award has been given to support travel to the Society for Investigative Dermatology (SID) Annual Meeting and participation in the concurrent CTCL Symposium. Due to the positive response of the initial award in 2011, a second award was offered to an investigator presenting at the American Society of Hematology (ASH) Annual Meeting. In 2019 additional travel awards were offered to the European Organization for Research and Treatment of Cancer (EORTC) and World Congress of Cutaneous Lymphomas (WCCL) meetings.
Criteria for selection of the Young Investigator Travel Award include:
- Individuals with a MD or PhD degree.
- Individuals with an academic rank no greater than assistant professor.
- Individuals with demonstrable interest and/or achievement in clinical care, education or research in cutaneous lymphomas.
- Individuals who have submitted an abstract and will presenting research at one of the aforementioned annual medical meetings.
2019 American Society of Hematology (ASH) Young Investigator Travel Award Recipient
- Pia Rude Nielsen, MD, PhD student, Zealand University Hospital, Institute for Clinical Medicine, Copenhagen University, "Diagnostic 2-Gene Classifier in Early-Stage Mycosis Fungoides: A Retrospective Multicenter Study"
2019 European Organization for Research and Treatment of Cancer (EORTC) Young Investigator Travel Award Recipient
- Saritha Kartan, MD, PhD, FAAD, Thomas Jefferson University, Sidney Kimmel Cancer Center, "Response to topical corticosteroid monotherapy in mycosis fungoides"
2019 Society of Investigative Dermatology (SID) Young Investigator Travel Award Recipients
- Amrita Goyal, MD, University of Minnesota, "Epidemiology of primary cutaneous gamma/delta T-cell lymphoma and subcutaneous panniculitis-like T-cell lymphoma in the United States from 2006-2015: A Surveillance, Epidemiology, and End Results-18 analysis"
- Shamir Geller, MD, Memorial Sloan Kettering Cancer Center and the Tel Aviv Medical Center, "CCR4 expression in CD8+ cutaneous T-cell lymphomas and lymphoproliferative disorders and its implications for diagnosis and treatment"